
#459 DIGEST: Finerenone for Heart Failure, PCV21 and the latest Pneumonia Vaccine Recs, 24-hour vs 15-hour Oxygen Therapy, and PREVENT vs PCE for Cardiovascular Risk Estimation
The Curbsiders Internal Medicine Podcast
00:00
Innovations in Heart Failure Treatment
This chapter explores pivotal developments in heart failure management, focusing on the new medication finerenone and its significance in recent clinical trials. The speakers analyze the implications of the Fine Arts Heart Failure Trial and contrast it with previous studies like TOPCAT, shedding light on treatment efficacy and patient outcomes. The discussion also highlights pneumonia vaccination updates, emphasizing the importance of preventative measures for older adults.
Transcript
Play full episode